Privia Health Group, Inc. · NASDAQ:PRVA

Privia Health — Q2 2026 Earnings Presentation

19 slides from Privia Health's earnings presentation, Aug 6, 2026

  1. Slide 1: 2nd Quarter 2026 Results

    2nd Quarter 2026 Results Parth Mehrotra, CEO August 6, 2026 David Mountcastle, CFO

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2026 financial guidance

  3. Slide 3: Agenda

    Agenda ● Key Highlights ● 2Q and 1H’26 Performance ● 2026 Guidance and Outlook ● Q&A 3

  4. Slide 4: Strong Second Quarter Performance

    Strong Second Quarter Performance ● Strong 2Q’26 performance and operational execution ○ Implemented Providers growth +10.1% vs. 2Q’25 ○ Attributed Lives growth +19.2% vs. 2Q’25 ○ Practice Collections growth +12.4% vs. 2Q’25 ○ Adjusted EBITDA1 growth +29.0% (28.3% margin, +310 bps) vs. 2Q’25 ● Enter

  5. Slide 5: Building One of the Largest Primary Care Centric Delivery Networks

    Building One of the Largest Primary Care Centric Delivery Networks 1 NATIONAL PRESENCE 25 States + Includes 9 VBC-only States D.C. 50+ Specialties 1,300+ Care Center Locations 6.1M+ Patients 1.64M+ Attributed Lives* 5,644 Implemented Providers ** 98% Gross Provider Retention*** Implemented Providers

  6. Slide 6: Diversified Value-Based Platform

    Diversified Value-Based Platform 1 1.64+ Million 130+ Total Attributed Lives VBC Contracts 942K 705K Commercial Government • 61% Upside Only Lives Lives • 39% Upside / Downside 340K 230K CMS Medicare 136K Medicare Medicaid Advantage program Lives Lives Lives • 83% Enhanced Track/ • 71% Upside Only •

  7. Slide 7: $15.7 Billion in VBC Medical Spend Under Management

    $15.7 Billion in VBC Medical Spend Under Management 1 $15.7 Billion Total Medical Spend Under Privia VBC Contracts $7.0B $8.7B Commercial Government Medical Medical • 61% Upside Only Spend Spend • 39% Upside / Downside $4.8B $3.3B $0.7B MSSP MA Medicaid Medical Medical Medical Spend Spend Spend • 83

  8. Slide 8: 2Q Performance

    2Q Performance 1 Implemented Providers Attributed Lives Practice Collections ($mm) (end of period) (‘000s, end of period)1 +10.1% +19.2% +12.4% Care Margin ($mm) Platform Contribution ($mm) Adjusted EBITDA ($mm) +14.7% +20.1% +29.0% % Practice Collections 6.7% 7.1% % Practice Collections 3.4% 3.9% %

  9. Slide 9: Six Month Performance

    Six Month Performance 1 Practice Collections ($mm) Care Margin ($mm) +13.4% +18.3% Platform Contribution ($mm) Adjusted EBITDA ($mm) +24.5% +32.5% % Practice Collections 6.6% 7.2% % Practice Collections 3.4% 3.9% % Care Margin 49.5% 52.1% % Care Margin 25.2% 28.3% 1 9 Any slight variations in calcul

  10. Slide 10: Strong Balance Sheet and Capital Position

    Strong Balance Sheet and Capital Position ● $412.2M in net cash and no debt as of 6.30.26 ● Full cash tax payer in FY’26 ● Final MSSP 2025 results expected in November 2026 ● Expect 70-80% of FY’26 Adjusted EBITDA1 to convert to Free Cash Flow2, subject to timing of MSSP cash settlement (In millions

  11. Slide 11: Updated FY'26 Guidance Metrics

    Updated FY’26 Guidance Metrics 1 Initial FY’26 Guidance Updated FY’26 Guidance FY’25 Actual ($ in millions) at 2.26.26 at 8.6.26 Low High Implemented Providers 5,380 5,900 6,000 No Change Attributed Lives 1,541,000 1,550,000 1,600,000 1,625,000 - 1,650,000 Practice Collections $ 3,470.5 $ 3,650 $ 3,

  12. Slide 12: Consistent Growth & Profitability Across Cycles

    Consistent Growth & Profitability Across Cycles 1 MA / MEDICAID PRE-COVID COVID POST-COVID HEADWINDS 1 Any slight variations in percentages are due to rounding. Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures because the Company cannot p

  13. Slide 13: Appendix

    Appendix 13

  14. Slide 14: Reconciliation of Gross Profit to Care Margin

    Reconciliation of Gross Profit to Care Margin l 14

  15. Slide 15: Reconciliation of Gross Profit to Platform Contribution

    Reconciliation of Gross Profit to Platform Contribution m 15

  16. Slide 16: Reconciliation of Net Income to Adjusted EBITDA

    Reconciliation of Net Income to Adjusted EBITDA n 16

  17. Slide 17: Reconciliation of Gross Profit to Care Margin

    Reconciliation of Gross Profit to Care Margin 17

  18. Slide 18: Reconciliation of Net Income (Loss) to Adjusted EBITDA

    Reconciliation of Net Income (Loss) to Adjusted EBITDA 18

  19. Slide 19: Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

    Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow 19

Privia Health Group — Q2 2026 Earnings Presentation on 6ix